INTERNATIONAL PATENT: PLUTO IMMUNOTHERAPEUTICS, INC. FILES APPLICATION FOR "HYBRID ANTI-CD20 CAR T CELL THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES"

GENEVA, May 12 -- PLUTO IMMUNOTHERAPEUTICS, INC. (570 Westwood PlazaLos Angeles, California 90095) filed a patent application (PCT/US2025/053023) for "HYBRID ANTI-CD20 CAR T CELL THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES" on Oct 29, 2025. With publication no. WO/2026/096570, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MONTEL-HAGEN, Amelie (1417 Butler Avenue, Apt 301Los Angeles, California 90025)

Abstract: The present disclosure provides a method of treating autoimmune diseases such as multiple sclerosis, comp...